New vaccine aims to train immune system against lymphoma
⭐️ VACCINE ⭐️
Recruiting now
This study tests a new vaccine (EO2463) designed to help the immune system fight indolent non-Hodgkin's lymphoma, a slow-growing blood cancer. About 80 adults with follicular or marginal zone lymphoma will receive the vaccine alone or combined with standard drugs lenalidomide and…
Phase: PHASE1, PHASE2 • Sponsor: Enterome • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:00 UTC